Interim Results on the Influence of Lanreotide on Uptake of [68Ga]-DOTATATE in Patients With Metastatic or Unresectable NET: No Evidence for Discontinuation of Lanreotide Before [68Ga]-DOTATATE PET/CT
Clinical Advances in Hematology and Oncology H&o 14(5 Suppl. 7): 13-15
2016
ISSN/ISBN: 1543-0790 PMID: 27168107 Document Number: 16615
Preliminary results suggest that lanreotide depot/autogel does not negatively impact imaging results of NETs with 68Ga-DOTATATE.
Document emailed within 1 workday
![Interim Results on the Influence of Lanreotide on Uptake of [68Ga]-DOTATATE in Patients With Metastatic or Unresectable NET: No Evidence for Discontinuation of Lanreotide Before [68Ga]-DOTATATE PET/CT](https://img.popline.org/16615.webp)
Related Documents
Moubax, K.; Mana, F.; Urbain, D. 2014: Resolving bile reflux by lanreotide in patients with Roux-en-Y gastrojejunostomy Acta Gastro-Enterologica Belgica 77(4): 377-378Moubax, K.; Mana, F.; Urbain, D. 2014: Resolving bile reflux by lanreotide in patients with Roux-en-Y gastrojejunostomy Acta Gastro-Enterologica Belgica 77(4): 377-378
2016: Tumor Growth Rate (TGR) as an Indicator of Antitumor Activity With Lanreotide Autogel/Depot (LAN) Versus Placebo (Pbo) in Intestinal/Pancreatic NET: Post Hoc Analysis of CLARINET Data Clinical Advances in Hematology and Oncology: H&o 14(5 Suppl. 7): 6-7
Sukaraphat, N.; Chewaskulyong, B.; Buranapin, S. 2016: Dietary Counseling Outcomes in Locally Advanced Unresectable or Metastatic Cancer Patients Undergoing Chemotherapy Journal of the Medical Association of Thailand 99(12): 1283-1290
Ndase, P.; Celum, C.; Campbell, J.; Bukusi, E.; Kiarie, J.; Katabira, E.; Mugo, N.; Tumwesigye, E.; Wangisi, J.; Were, E.; Brantley, J.; Donnell, D.; Baeten, J.M. 2014: Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience Journal of Acquired Immune Deficiency Syndromes 66(2): 206-212
Kortmann, B.A.; Hoitsma, H.F. 1996: Continent ileostomy following discontinuation of ileoanal anastomosis with ileum reservoir; good results in 7 patients Nederlands Tijdschrift Voor Geneeskunde 140(18): 984-987
Majerović, M.; Augustin, G.; Jelincić, Z.; Buković, D.; Kekez, T.; Matosević, P.; Smud, D.; Kinda, E.; Golem, A.Z. 2008: Radiofrequency ablation as locoregional therapy for unresectable hepatic malignancies: initial results in 24 patients with 5-years follow-up Collegium Antropologicum 32(3): 703-707
Iwasa, S.; Shimada, Y. 2011: Treatment strategy of chemotherapy for unresectable metastatic or recurrent colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 427-432
Wilkes, G.M. 2011: Ipilimumab, a human monoclonal antibody for treatment of unresectable or metastatic melanoma Oncology 25(7 Suppl Nurse Ed): 46-47
Murray, J.L.; Macey, D.J.; Grant, E.J.; Rosenblum, M.G.; Kasi, L.P.; Zhang, H.Z.; Katz, R.L.; Riger, P.T.; LeBherz, D.; Bhadkamkar, V. 1995: Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment Cancer Research 55(23 Suppl): 5925s-5928s
Attia, S.; Holen, K.D.; Thomas, J.P.; Richie, K.; Dzelak, T.; Teeter, K.; Warren, D.; Bilger, A.; Fine, J.; Eickhoff, J.; Drinkwater, N.; Mulkerin, D.; Morgan-Meadows, S. 2008: Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma Clinical Advances in Hematology and Oncology: H&o 6(1): 44-54
Arakawa, S.; Horiguchi, A.; Tomishige, H.; Kawabe, N.; Nagata, H.; Ishihara, S.; Ito, M.; Asano, Y.; Ito, R.; Isetani, M.; Shimizu, K.; Kamio, K.; Kawai, T.; Yasuoka, H.; Imaeda, Y. 2018: Safety and Efficacy of TAS-102 with Bevacizumab for the Treatment of Unresectable Metastatic Colorectal Cancer - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(4): 649-651
Isoniemi, H.; Eklund, B.; Höckerstedt, K.; Korsbäck, C.; Salmela, K.; von Willebrand, E.; Häyry, P.; Ahonen, J. 1990: Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results Transplantation Proceedings 22(4): 1365-1366
Liang, B-Yong.; Huang, Z-Yong.; Zhou, S-Jun.; Hou, P.; Wang, S-Fa.; Jiang, B.; Chen, X-Ping. 2014: Primary results of salvage liver transplantation in the patients with unresectable recurrent hepatocellular carcinoma after initial liver resection Hepato-Gastroenterology 61(135): 2014-2020
1998: Interim procedures for certain health care workers--INS. Interim rule with request for comments Federal Register 63(198): 55007-55012
Osterwalder, J.J. 1992: The effect of first aid and care times on the clinical course and treatment results in multiple trauma. Initial interim results of an interdisciplinary trauma registry in the St. Gallen district hospital Schweizerische Medizinische Wochenschrift 122(42): 1571-1581
Volkova, M.I.; Matveev, V.B.; Matveev, B.P.; Gushcha, A.O. 2000: Results of surgical treatment of patients with kidney neoplasm metastatic to the brain Urologiia 6: 7-9
Ninan, P.T.; Knight, B.; Kirk, L.; Rothbaum, B.O.; Kelsey, J.; Nemeroff, C.B. 1998: A controlled trial of venlafaxine in trichotillomania: interim phase I results Psychopharmacology Bulletin 34(2): 221-224
Modey, E.J.; Aryeetey, R.; Adanu, R. 2014: Contraceptive discontinuation and switching among Ghanaian women: evidence from the Ghana Demographic and Health Survey, 2008 African Journal of Reproductive Health 18(1): 84-92
Modey, E.J.; Aryeetey, R.; Adanu, R. 2014: Contraceptive discontinuation and switching among Ghanaian women: evidence from the Ghana Demographic and Health Survey, 2008 African Journal of Reproductive Health 18(1): 84-92